Substance
MITOMYCIN
Global reference: every product and company linked to this substance.
- cas: 50-07-7
- ncit: C1820
- pubchem_cid: 5746
- rxnorm: 632
- unii: 50SG953SK6
AMETYCINE · JELMYTO · MITOCIN-C · mitomycin [INN] · MITOMYCIN [USAN] · Mitomycin [WHO-DD] · MITOMYCIN C [JAN] · MITOSOL · MUAMYCIN · MUTAMYCIN · MYTOZYTREX · NSC-26980
Revenue by product (2)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| UROGEN PHARMA LTD. ORDINARY SHARES | ZUSDURI | Q2 2026 | $50.4M |
| UROGEN PHARMA LTD. ORDINARY SHARES | JELMYTO | Q2 2026 | $22.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (5)
- JELMYTO · UROGEN PHARMA LTD. ORDINARY SHARES
- MITOMYCIN · PFIZER INC. COMMON STOCK
- MITOSOL · GLAUKOS CORPORATION COMMON STOCK
- MUTAMYCIN · BRISTOL-MYERS SQUIBB COMPANY COMMON STOCK
- ZUSDURI · UROGEN PHARMA LTD. ORDINARY SHARES